ERBB2 and cancer: Previous studies reported that NRG1 exerts its effects in cancers by directly binding to ERBB3 or ERBB4 which heterodimerizes with ERBB2 and the ligand-receptor interaction, causes the phosphorylation of receptors and activation of signaling cascades [40].